Technology
A Permanent Embolic Protection Solution
The Vine™ Filter is a permanent, bilateral common carotid artery (CCA) implant designed to intercept emboli before they reach the brain.
Constructed from a single nitinol wire, the Filter is engineered to provide permanent embolic protection.
- Configured to capture emboli ≥1.4 mm in size
- Anchoring system designed to prevent migration
- Integrated retrieval wire for bailout (up to 4 hours post implantation)
Embolic Protection | Complementary to Anticoagulation
Under evaluation for reducing the risk of recurrent LVO stroke in patients with Atrial Fibrillation
The Vine™ Implantation Procedure
- Ultrasound-guided
- May be performed at the patient’s bedside, in the cath lab, or in a surgical suite
- Total procedure time: typically less than 30 minutes
The Vine™ Inserter’s Reusable–Disposable Design
Needle Unit
A sterile, single-use 22G needle preloaded with the Filter (A).
Motor Unit
A reusable, non-sterile unit containing the motor and gear mechanism, shown in its charger (B).
Inserter
When the Motor Unit (B) is connected to the Needle Unit (A), the Inserter (C) is ready for Filter deployment upon activation.
FDA Breakthrough Device Designation
The Vine™ Filter was granted Breakthrough Device Designation by the FDA.
This designation highlights its potential to address an important unmet need in stroke prevention and enables a more streamlined path for development and review.
Existing Experience
The Vine™ Filter is built on a foundation of extensive preclinical testing and has been evaluated in two clinical studies in AF patients:
- CAPTURE, First-in-Human study
- CAPTURE 2, Safety study
- 106 patients treated
- Over 360 total patient-years of follow-up
Enroll Today!
Investigational device, limited by United States law to investigational use.